1/97
Looks like no tags are added yet.
USP 797 - This establishes a standard of practice for compounding sterile preparations.
This outlines the required procedures for compounding sterile preparations.
USP 797 - including hospital pharmacies, chemotherapy units, nuclear pharmacies, long-term care facilities, ambulatory care centers where there is a compounding sterile preparation activities
This applies to pharmacies that produce compounded sterile preparations
USP 797: Designed to protect both the patients and the pharmacists. Requires attention to three main areas to ensure compliance
Staff training and ongoing guidance Determination of the categories Development and implementation of appropriate policies and procedures
Parenteral Nutrition: also known as
Intravenous hyperalimentation
Parenteral Nutrition
Feeding of a patient by the intravenous infusion of fluids and basic nutrients (the delivery of nutrients is intravenous via the bloodstream)
Central Parenteral Nutrition
often called Total Parenteral Nutrition (TPN); delivered into a central vein
Peripheral Parenteral Nutrition (PPN)
delivered into a smaller or peripheral vein
Anticipated duration of parenteral nutrition
should be greater than or equal to 7 days (duration ≥ 7 days)
Total Parenteral Nutrition
IV administration of nutrients precisely formulated in such a manner that the totality of the patient's nutritional needs were satisfied.
Hypertonic solution - >300mOsm/L of dextrose and amino acids
It is designed to be a ____ so that the needed nutrients are provided in an amount of fluid that does not exceed the daily fluid capacity of the body
TPN: It was developed in ____, in the ____ — by ____
1960, University of Pennsylvania — by Dr. Stanley J. Dudrick, Dr. Jonathan E. Rhoads, Dr. Douglas Wilmore
TPN requires a ____ that empties into the superior or inferior vena cava
catheter or port
Total Nutrient Admixture or 3-in-1 or All-in-One Parenteral Nutrition
combination of carbohydrates, fats, and proteins - If lipid is added directly to the solution - Pre mixed: Vitrimix, Kabiven, Nutripack
2-in-1
combination of carbohydrates and proteins, the fat is separate
3-in-1 na nandito sa right side ng pic is Kabiven
Total Nutrient Admixture
Port of entry of TPN =
subclavian vein is the preferred port of entry because of reliable access points for temporary and permanent venous cannulation to support hemodynamic monitoring, fluid and medication administration, and parenteral nutrition. Also, the subclavian vein has low infection rate
Peripheral Parenteral Nutrition
Nutritional support that supplements oral intake and provide only part of the daily nutritional requirements. Patient needs IV nutritional support but does not have a central line Therapy is expected to be short term (10-14 days) Energy and protein needs are moderate It is given as a supplement to enteral feeding so the Formulation osmolarity is <600-900 mOsm/L Fluid restriction is not necessary
Goal of Therapy
To achieve adequate nutritional status and positive nitrogen balance until exercise and the utilization of nutrients via GIT is possible. Maintain weight and metabolic integrity Replete malnourished patients with deficits in lean body mass accompanied by deficits in visceral and serum proteins Restore hematologic and immune function integrity
Indication
Oral feeding is not feasible - Given intravenously to patients unable to assimilate nutrients via the GIT - Should be used only when the gut is not available Oral feeding is not enough - A patient with good nutritional reserves when it is anticipated that the GI tract will not be available for more than 7 days - The patient is severely malnourished or under moderate stress like if the patient underwent major surgery or its a ?? patient Oral feeding is not recommended - Especially for patients with nonfunctioning GI tract - If the patient has a severe malnutrition, short bowel syndrome, or intestinal obstruction. Oral feeding is dangerous - Patients who require bowel rest Can also be given to immunocompromised patients
PN is no value or little value:
Functional and accessible GI tract Patient is taking oral diet Good nutritional support Risk exceeds benefit End stage, terminally ill
TPN - Route of Administration
preferred nutritional supplement for a long time because it delivers through the central vein - comes in a higher concentration - can only be administered through a large vein such as the chest or neck
PPN - Route of Administration
only partially preferred because it is not safe to use hyperosmolar solutions in the peripheral vein for a very long time - comes in a lesser concentration - can be delivered to the peripheral vein
Dextrose concentration: - NMT 10% for adults and 12.5% for children - Because the osmolality of higher dextrose concentrations can cause phlebitis of peripheral veins - phlebitis - inflammation of the vein Amino acid: - Limited to a maximum of 5% in adults and 3.5% in children Advantages: - Simple, straight forward procedure Disadvantage: - Hypertonic solutions will cause thrombophlebitis and severe tissue necrosis Management: - Keep infusion site visible for regular inspection not concealed in dressing - Should be regularly re-sited, particularly in infants. - Must be changed at least every 3 days or when phlebitis occurs - Place infusion site where extravasation injuries are less disfiguring - Follow established protocols for dressing & management of ward. - Some add hydrocortisone 5mg/day, heparin 100-1000 units/day to help reduce phlebitis occurrence
phlebitis
inflammation of the vein
via femoral lines, internal jugular lines, and subclavian vein catheters Advantages: - No complications of thrombophlebitis or extravasation Disadvantages: - Catheter-related sepsis Management: - Requires scrupulous aseptic technique at all times by a trained staff
CENTRAL ACCESS
required for infusions that are toxic to small veins due to the pH, osmolarity, and volume of the medication
PICC Lines (Peripherally Inserted Central Catheter)
May be used in ambulatory settings or for long term therapy Used for delivery of medication as well as PN Via cephalic, basilic, median basilic, or median cephalic veins and threaded into the superior vena cava Can remain in place for up to 1 year with proper maintenance and without complications
Macronutrients: Carbohydrate
Source: - Dextrose 50% or 70% - 3.4kcal/g Properties: Energy source Final dextrose concentration: - Central Vein - ~25% - Peripheral Vein - maximum of 10-12.5%
Macronutrients: Proteins
Source: - Crystalline amino acids — standard or specialty - 8.5%, 10%, 15% Properties: 4.0 kcal/g Example (pic): amino acid - Aminoleban® solution and Aminoleban® ORAL (orange flavored powder)
Macronutrients: Lipids
Source: - Lipofundin 10%, 20%, Liposyn, Intralipids Properties: 10 kcal/g Prevents essential fatty acid deficiency Lipids supply a large percentage of energy requirements. This may be given separately or in solution to minimize the development of phlebitis. To prevent hyperlipidemia, lipid emulsions are not provided continuously - to give the body to clear the lipids in the blood. It is generally administered at least 2 to 3 times a week, but it can be provided daily.
Micronutrients: Fluids
Source: - Sterile water for injection - To meet fluid requirements Recommended intake: - 30 to 50 mL/kg (1.5 to 3 L/day)
Micronutrients: Electrolytes
Source: - Generally present in most foods - To meet daily metabolic needs - Na, K, Cl, Ca - NaCl, Na3PO4, KCl, Ca gluconate, Ca acetate, MgSO4 Electrolytes are calculated based on the health status of the patient
Sodium (Na)
helps control distribution and maintain the normal fluid balance.
Potassium (K)
is needed for cellular activity and tissue synthesis.
Magnesium (Mg)
helps absorb carbohydrates and proteins.
Calcium (Ca)
is needed for bone and teeth developments. Also aids in clotting.
Phosphate (PO4)
plays a crucial role in metabolic pathways
Chlorine (Cl)
regulates the acid-base equilibrium and maintains osmotic pressure.
Micronutrients: Vitamins
Essential in the metabolism of CHO, CHON & fats - CHO - carbohydrates - CHON - proteins Vit. B & C Vit. A, D, E, & K - Added once and twice a week MVI - multiple vitamin infusion - Example (pic) - MULTIDEX - commercially prepared multivitamins + dextrose
Vit. A
helps maintain integrity of the skin; essential to vision
Vit. B
needed in the absorption of carbohydrates and proteins
Vit. C
helps in wound healing
Vit. D
essential for bones and maintenance of serum calcium levels
Vit. K
prevents bleeding disorders
Micronutrients: Trace Elements
For proper enzymatic reactions Zn, Cu, Mn, Cr Iron - not routinely added because it changes the pH of the solution - iron supplementation should be limited to conditions of iron deficiency Helps in wound healing and red blood cell synthesis Reduction in manganese and copper dosing should be considered in patients with hepatobiliary disease due to impaired excretion
Nutrition Support Team
In order to assure patients of maximum efficient and proper nutrition support for their nutritional needs
Nutrition Support Team: Objectives
To standardize the practice of providing nutritional support to hospitalized patients. To centralize all activities regarding nutritional support to a team of experts. To recommend policies and guidelines to the hospital regarding proper and up-to-date practices in nutritional support of patients. To provide expert advice and consult to physicians needing help in the nutritional support of their patients.
Nutrition Support Team: Members
Physician - Chairman of NST Nurse Pharmacist Dietician Physical Therapist Social worker Medical Technologist
NST Member: Physician - Chairman of NST
Clinical decision regarding the safety and effectiveness of TPN therapy Identifies the candidates for TPN therapy Reviews the nutritional assessment data Responsible for catheter placement Prescribes appropriate formulations to be compounded by the pharmacists Establish goals of therapy Directs patient monitoring
NST Member: Nurse
Reassure the patient about the procedure Gathers necessary items for catheter placement Prepares patient - emotionally and physically for the procedure to be done Assist the physician in the insertion of the catheter Arranges the appropriate IV apparatus Takes charge of the maintenance of the catheter site Cares for the catheter site Participates in patient monitoring
NST Member: Pharmacist
Prepares parenteral nutrition Knowledge of additive compatibility or incompatibility and drug interactions Inform the physician if there is any suspected errors in the ordering of parenteral nutrition. Inform the physician of the need for the substitute drugs. Knowledge of various TPN substrates
NST Member: Dietician
Helps in the patient's nutritional assessment Enteral feeding Manages the transitional feedings from parenteral to enteral route.
NST Member: Physical Therapist
Exercise program designer
NST Member: Social worker
Emotional and financial support
NST Member: Medical Technologist
Laboratory tests
Clinical Management
Start slowly, increased gradually; and end vice-versa - start TPN slowly so that the body will have the time to adapt to both of the glucose load and the hyperosmolarity of the solution, to avoid the fluid overload Choice of administration route depends on final osmolarity of mixture Clinical monitoring is required at the start of any infusion. Any abnormalities, the infusion is stopped. Frequent clinical evaluation and laboratory tests are necessary for correct monitoring during drug administration. IV flow rate should be maintained with 20% of that ordered. Any sustained rapid increase in fluid infusion can cause hyperglycemia, glucosuria, and osmotic diuresis. Vital signs should be taken every 4 hours around the clock. Weigh daily. Any weight gain in excess of ½ pound per day may be due to excess fluid retention. Use same scale, same time, with similar articles of clothing. Catheter is changed every other day or when clinically indicated. Patient should be ambulated when possible. Exercise enhances the achievement of N balance and restitution of muscle mass.
Additive Compatibility
Do not add antibiotics, steroid, and pressor agents. - in the parenteral nutrition Na bicarbonate is not compatible with Ca or MgSO4 High dextrose + whole blood = clumping of RBC’s Vitamin K is activated by Vitamin C in solution Ca gluconate may cause false depression in serum and urine Mg levels when Titan yellow method for determining Mg is used. Insulin in TPN is effective, but it may be unstable in the presence of Na bicarbonate. Physical separation may occur if not mixed thoroughly. Albumin - visually compatible for 24 hours, but increase risk for fungal and bacterial growth. Occlusion of filters occur if concentration of Albumin exceeds 25 g/L. Lipids, infused by Y - line near the infusion site. - Lipid emulsion obscure the presence of precipitate, therefore if a lipid emulsion is needed, it would be infused separately
Additive Compatibility (Sidenotes)
when adding calcium or phosphate to an admixture, phosphate should be added first to prevent precipitation during the mixing process, the pharmacist should periodically agitate the mixture and check for the presence of precipitates before and during the infusion
Pharmaceutical Precautions
Store below 25°C. Do not freeze - if stored in a room temperature, infusion should be started within 24 hours after mixing - if refrigerated, should be started within 24 hours after rewarming once administration begin - once administration begin, care should be taken to avoid excess rewarming of the admixture - excessive rewarming of the admixture may sometimes cause precipitation Do not administer simultaneously with, before and after an administration of blood through the same infusion equipment due to pseudoagglutination Once prepared, use immediately or refrigerate. Remove from refrigeration 1 hour prior to infusion to reach approximately room temperature. - there is a rewarming Once hung, must be infused or discarded within 24 hours. - if not used No medications should be added to TPN lines once they are infusing, except lipid emulsion.
TPN Form
Preprinted order forms Reduce error May be required in some hospitals - Each facility designs components of preprinted forms
TPN Form (Sidenotes)
in initiating parenteral nutrition, the parenteral nutrition or the ring system should be established in every hospital, in every institution to uniformly reduced prescription error TPN form should be properly/clearly filled out and should be understandable to anyone who will utilize the form the design of the preprinted forms depends on the institution or the facility important/necessary information should be indicated (e.g. route of administration, the rate and the time of infusion, ingredients, concentration) should be organized so that it can be easily scan for any errors
INITIATING PARENTERAL NUTRITION
Start slow: 1 L - 1st day; 2 L - 2nd day Infusion rate may be increased as glucose tolerance permits Maximum amount of protein on the first day - up to 60-70 grams/liter - as proteins are associated with the few metabolic side effects Maximum CHO given on the first day: 150-200 g/day or a 15-20% final dextrose concentration Glucose intolerance, 100-150 g dextrose or 10-15% glucose concentration If 24 hr TPN is to be discontinued, the rate of administration is slowed to prevent rebound hypoglycemia (especially for infants and children) Parenteral nutrition is discontinued when enteral or oral intake achieves ⅔ of the patient’s estimated needs. Generally energy and protein needs can be met in adults by day 2 or 3 In neonates and pediatrics, time to reach full support relates inversely to age, may be 3-5 days
CONTINUOUS PN
Non-interrupted infusion of a PN solution over 24 hours via a central or peripheral venous access It is infused at a constant rate controlled by a pump Advantages: - Well tolerated by most patients - Requires less manipulation - ↓ nursing time - ↓ potential for “touch” contamination Disadvantages: - Persistent anabolic state - altered insulin : glucagon ratios - increased lipid storage by the liver - Reduces mobility in ambulatory patients
CYCLIC PN
Intermittent administration via a central or peripheral venous access, usually over a period of 12 - 18 hours Patients on continuous therapy may be converted to a cyclic PN over 24-48 hours Advantage: - Approximates normal physiology of intermittent feeding - Maintains: - Nitrogen balance - Visceral proteins - Ideal for ambulatory patients - Allows normal activity - Improves quality of life Disadvantage: - Incorporation of N2 into muscle stores may be suboptimal - Nutrients administered when patient is less active - Not tolerated by critically ill patients - Requires more nursing manipulation - Increased potential for touch contamination - Increased nursing time
Cyclic PN (Sidenotes)
intermittent - occurring in irregular interval if the patient is to nourished with TPN for an extended period of time, cyclic PN is employed if the patient is fed during the night and fasting during the day, cyclic PN is employed cyclic PN helps prevent hepatotoxicity that can be developed on a long-term used the fasting period allows the fatty acids to be released from the fat store
Aseptic Preparation
Involves procedures designed to preclude contamination by microorganisms during processing.
Aseptic Preparation - there is a free from contamination
Ability of the personnel to handle the sterile components of these IV solutions in the clean environment of a Laminar flow hood without introducing viable microorganisms in the product.
Aseptic Preparation (procedures)
Thorough hand-washing with appropriate antimicrobial. Wearing of protective clothing, mask, head cover, shoes and gloves. - remove all makeup, no jewelries, do not touch the face and the hair Disinfection of non-sterile materials to be used.
Sources of product contamination
People (most common) - Touch contamination - Generation of particulates from shedding cells or hair Air supply - Heating Ventilation and Air Conditioning (HVAC) Infiltration - Particles from adjacent spaces (e.g. anteroom) Internal generation - Walls, floors, ceilings, packaging, equipment
Importance of Aseptic Technique
Parenteral administration bypasses the skin and gastrointestinal tract, the bodies natural barriers to infection Giving a patient a contaminated product can cause serious adverse effects including DEATH Parenteral medications account for >40% of all medications administered in institutional practice - that is why we really have to practice aseptic technique in a hospital
Laminar Flow Workbenches: Principle
Constant flow of HEPA filtered air Continuously sweeps the work area Prevents the entry of contaminated air
HEPA filter
High Efficiency Particulate Air filter removes 99.97% of all air particles 0.3mm or larger
Horizontal LAFW (Laminar Flow Hood) Vertical LAFW (biological safety cabinets (BSCs or Chemotherapy Hood)
Laminar Flow Workbenches: 2 Types
Horizontal LAFW (Laminar Flow Hood)
Air moves from back to front Used for non-chemotherapy preparations Most common for sterile preparations of IV solutions Should be cleaned or replaced on regular basis Entire back portion of hood’s work area is HEPA Removes 99.97% of particles that are 0.3 micron or larger - the hood prevents contamination of compounded sterile products and parenteral preparations
Vertical LAFW (biological safety cabinets (BSCs or Chemotherapy Hood)
Air emerges from the top and passes downward Exposure to airborne drug particles minimized Used for preparation of antineoplastics Must prevent downstream contamination Zone of turbulence - air turbulence created inside the critical area by introduction of an object in a direct path - could potentially extend outside the hood pulling/allowing contaminated air into the aseptic work area - the BSC is designed to protect the pharmacist, pharmacy technician, or anyone who will prepare the preparation from exposure to hazardous medications
Zone of turbulence
air turbulence created inside the critical area by introduction of an object in a direct path - could potentially extend outside the hood pulling/allowing contaminated air into the aseptic work area
Zone of turbulence (sidenote)
when the laminar airflow is moving on all sides of the object, the zone of turbulence extends 3 times the diameter of the object but if the laminar airflow is not accessible to both sides of the object, the zone of turbulence extends 6 times the diameter of the object
Laminar flow hood (sidenote)
it is advisable to work with objects 6 inches from the side and front edge without blocking the bench(?)
6 inches - to prevent the possibility of contamination from room air and tiring(?) a hood
All aseptic manipulations should be performed at least ____ within the hood.
15-30 minutes
Hood: Must run for ____ if turned off and back on
All interior working surfaces should be cleaned
70% isopropyl alcohol/other disinfecting agent Clean, lint-free cloth
Clean Room
Specifically constructed room in which the air supply, air distribution, dust and airborne particles, room pressure, temperature and humidity are environmentally regulated to meet appropriate cleanliness level.
Aseptic preparation
Demands meticulous “NO - TOUCH” technique, EVERY TIME! Aseptic technique requires specific manipulations for: - Syringes - Needles - Vials - Ampules - Removal of packaging - Assembling of sterile products - Hand placement
Aseptic preparation: Syringe
NEVER TOUCH Tip or Plunger Open syringe package in hood Peel wrapper and discard out of hood Leave syringe tip protector in place until time to attach needle To attach needle to Luer-lock-type syringe ¼ turn is usually sufficient to secure needle to syringe
Coring
The development of a core or hole in the rubber of a vial - To prevent coring insert needle as shown - Insert the bevel tip first, then pressing downward and toward the bevel so the bevel tip and heel enter at the same point
Needle size is determined by two numbers
Gauge Length
The larger the gauge number
the finer the diameter of the needle’s bore - 27 gauge needle finer than 13 gauge needle - Common needle sizes at UK include - 16G 1&½ inch - 18G 1&½ inch - 20G 1 inch
gauge
is the outer diameter of the needle
Needles and syringes (sidenotes)
it is important that when using needles and syringes in product preparation, they are not to be removed from the hood workspace needles and syringes, after using, must be properly disposed in the sharp container located near the hood to prevent injury to others NEVER disposed needles and syringes in a regular trash
Aseptic preparation: Vials and Ampules - To prevent contamination
Swab rubber closure with 70% alcohol using firm strokes in the SAME direction
Aseptic preparation: Vials and Ampules - To prevent core formation
Insert needle to penetrate the rubber closure at same point with both tip and heel of bevel
Aseptic preparation: Vials and Ampules - To prevent vacuum formation
Inject an equal amount of air for the volume of fluid to be removed
Aseptic preparation: Vials and Ampules - Reconstituting drug powder
Remove an equal amount of air for the volume of diluent added
Aseptic preparation: Vials and Ampules - To break ampule
Clean ampule neck with alcohol swab Leave swab in place Grasp ampule neck with thumb and index finger Use quick, firm, snapping motion away from body towards side wall of hood DO NOT BREAK TOWARD HEPA FILTER
tilt the ampule break the neck place the bevel in the corner space near the opening pull back the syringe plunger
to withdraw medication from the ampule
filter needle can only be used in one direction
to avoid glass contamination of ampule solution, use 5 micron filter needle to filter glass as solution is push out of the syringe
Aseptic preparation: Removing Packaging
Any sterile component or supply (e.g., syringes, needles, and ampules) should only be opened and/or removed from their packaging within the laminar-flow workspace. When opening the wrapper on a needle, it should be peeled open. Tearing paper introduces paper particles into the hood which could lead to product contamination. - no tearing of paper inside the hood
Beyond-Use Date
Beyond-use date based where the compounded preparation is being made: Category 1 Facility (PEC/C-PEC located in an SCA or C-SCA) beyond use date (BUD) is: - primary engineering control - 12 hours or less at controlled room temperature - 24 hours or less when refrigerated Category 2 Facility (located in a Buffer Room with an anteroom) beyond use date can be: - Greater than 12 hours at controlled room temperature - Greater than 24 hours when refrigerated The chemical stability of some drugs may be shorter than the default BUDs - the pharmacists should keep this in mind